Anti-Mullerian Hormone Clinical Trial
Official title:
Anti-Mullerian Hormone Levels Variations Following an Open Myomectomy
Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. It is well known that ovarian
surgery for endometriosis lowers Anti-Mullerian hormone, but little is known for other
surgeries. We seek to investigate the hormone variations before and after an open myomectomy.
Hypothesis: Anti-Mullerian hormone levels drop following surgery but return to normal levels
in a few months
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03131388 -
Clinical Performance Evaluation of AMH Assay
|
||
Active, not recruiting |
NCT00928044 -
The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH)
|
N/A |